DK4441052T3 - Forbindelser - Google Patents
ForbindelserInfo
- Publication number
- DK4441052T3 DK4441052T3 DK22803213.2T DK22803213T DK4441052T3 DK 4441052 T3 DK4441052 T3 DK 4441052T3 DK 22803213 T DK22803213 T DK 22803213T DK 4441052 T3 DK4441052 T3 DK 4441052T3
- Authority
- DK
- Denmark
- Prior art keywords
- connections
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21211778 | 2021-12-01 | ||
| PCT/EP2022/078724 WO2023099072A1 (en) | 2021-12-01 | 2022-10-14 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4441052T3 true DK4441052T3 (da) | 2026-02-23 |
Family
ID=78820625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK22803213.2T DK4441052T3 (da) | 2021-12-01 | 2022-10-14 | Forbindelser |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20250042918A1 (da) |
| EP (1) | EP4441052B1 (da) |
| JP (1) | JP2024544019A (da) |
| KR (1) | KR20240110971A (da) |
| CN (1) | CN118401527A (da) |
| AU (1) | AU2022399786A1 (da) |
| CA (1) | CA3239257A1 (da) |
| CL (1) | CL2024001611A1 (da) |
| DK (1) | DK4441052T3 (da) |
| ES (1) | ES3063655T3 (da) |
| FI (1) | FI4441052T3 (da) |
| IL (1) | IL313022A (da) |
| MX (1) | MX2024006741A (da) |
| PT (1) | PT4441052T (da) |
| WO (1) | WO2023099072A1 (da) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| PH12012501361A1 (en) | 2009-12-31 | 2012-10-22 | Centro Nac De Investigaciones Oncologicas Cnio | Tricyclic compounds for use as kinase inhibitors |
| EP2734205B1 (en) * | 2011-07-21 | 2018-03-21 | Tolero Pharmaceuticals, Inc. | Heterocyclic protein kinase inhibitors |
-
2022
- 2022-10-14 KR KR1020247021142A patent/KR20240110971A/ko active Pending
- 2022-10-14 MX MX2024006741A patent/MX2024006741A/es unknown
- 2022-10-14 EP EP22803213.2A patent/EP4441052B1/en active Active
- 2022-10-14 JP JP2024533077A patent/JP2024544019A/ja active Pending
- 2022-10-14 PT PT228032132T patent/PT4441052T/pt unknown
- 2022-10-14 DK DK22803213.2T patent/DK4441052T3/da active
- 2022-10-14 IL IL313022A patent/IL313022A/en unknown
- 2022-10-14 ES ES22803213T patent/ES3063655T3/es active Active
- 2022-10-14 AU AU2022399786A patent/AU2022399786A1/en active Pending
- 2022-10-14 FI FIEP22803213.2T patent/FI4441052T3/fi active
- 2022-10-14 CA CA3239257A patent/CA3239257A1/en active Pending
- 2022-10-14 US US18/714,621 patent/US20250042918A1/en active Pending
- 2022-10-14 WO PCT/EP2022/078724 patent/WO2023099072A1/en not_active Ceased
- 2022-10-14 CN CN202280079133.5A patent/CN118401527A/zh active Pending
-
2024
- 2024-05-29 CL CL2024001611A patent/CL2024001611A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT4441052T (pt) | 2026-02-19 |
| CA3239257A1 (en) | 2023-06-08 |
| KR20240110971A (ko) | 2024-07-16 |
| AU2022399786A1 (en) | 2024-07-04 |
| EP4441052A1 (en) | 2024-10-09 |
| IL313022A (en) | 2024-07-01 |
| CL2024001611A1 (es) | 2024-11-15 |
| US20250042918A1 (en) | 2025-02-06 |
| MX2024006741A (es) | 2024-06-19 |
| EP4441052B1 (en) | 2025-11-19 |
| WO2023099072A1 (en) | 2023-06-08 |
| JP2024544019A (ja) | 2024-11-26 |
| FI4441052T3 (fi) | 2026-02-17 |
| ES3063655T3 (en) | 2026-04-17 |
| CN118401527A (zh) | 2024-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4186256C0 (en) | INTER-AGENCY COMMUNICATION VIA AN AD-HOC NETWORK SLICE | |
| EP4137404A4 (en) | Multicopter | |
| EP4222352A4 (en) | BOLTER | |
| EP4107782A4 (en) | MICROARRAYS | |
| EP4223314A4 (en) | LIPID NANOPARTICLE | |
| EP4272364A4 (en) | TA NTN REPORT | |
| EP4217273C0 (en) | Rotorcraft | |
| EP3957265A4 (en) | MICROSCOPE COVER | |
| EP4063561C0 (en) | REFINER SEGMENT | |
| EP4163277C0 (en) | NEW PYRAZOLE DERIVATIVES | |
| EP4274436A4 (en) | Combination therapies | |
| EP4192823C0 (en) | TRIAZOLES DIFLUOROMETHYL-PYRIDIN-2-YL | |
| EP4154884A4 (en) | Anti-sars-cov-2 durg | |
| EP4137402A4 (en) | MULTICOPTER | |
| EP4320051A4 (en) | Pod capsules | |
| EP4228051A4 (en) | LEAD STORAGE BATTERY | |
| EP4221968C0 (de) | Radialpresse | |
| EP4288727C0 (de) | Cryosauna | |
| EP4280865A4 (en) | Epichloë Endophyte | |
| DK4441052T3 (da) | Forbindelser | |
| EP4267809A4 (en) | A connector | |
| EP4173688C0 (en) | MEDIA TANK | |
| EP4359654C0 (en) | MICRO-COPRODUCER | |
| EP4163199A4 (en) | Planing boat | |
| EP4358690C0 (en) | SEED COMPANY |